Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

VER:LN

46.500 GBp 1.000 2.20%

As of 12:35:16 ET on 03/27/2015.

Company Profile for Vernalis PLC (VER)

Vernalis plc is a revenue generating development stage pharmaceutical company which has a broad pipeline of research and development programs. The Company is focused on developing products for the US prescription cough and cold market. The Company derives pipeline candidates both from collaborations with global pharmaceutical businesses and their own research activities.

Contact Information

Vernalis PLC

Oakdene Court
613 Reading Road
Winnersh, RG41 5UA
United Kingdom
Phone: 44-118-977-3133
Fax: 44-118-989-9300

Key Executives for Vernalis PLC (VER)

Ian GarlandChief Executive OfficerDavid MackneyChief Financial Officer
Tom ParkerSenior VP:Commercial OperationsPascal BorderiesSenior VP:Medical Affairs
Kevin KissaneSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil